Advertisement
Life Sciences
Subscribe to Life Sciences

The Lead

Tasting light

January 30, 2015 4:21 pm | by Anne Trafton, MIT News Office | News | Comments

Human taste receptors are specialized to distinguish several distinct compounds: sugars taste sweet, salts taste salty, and acidic compounds taste sour. Now a new study from Massachusetts Institute of Technology finds that the worm Caenorhabditis elegans has taken its powers of detection a step further: The worm can taste hydrogen peroxide, triggering it to stop eating the potentially dangerous substance.

Why do zebras have stripes?

January 30, 2015 8:53 am | by Stuart Wolpert, Univ. of California, Los Angeles | Videos | Comments

One of nature’s fascinating questions is how zebras got their stripes. A team of life scientists...

DNA nanoswitches reveal how life’s molecules connect

January 30, 2015 8:17 am | by Kat J. McAlpine, Wyss Institute for Biologically Inspired Engineering | News | Comments

A complex interplay of molecular components governs most aspects of biological sciences: healthy...

Obama proposes "precision medicine" to end one-size-fits-all

January 30, 2015 6:18 am | by Lauran Neergaard, AP Medical Writer, Associated Press | News | Comments

President Barack Obama is calling for an investment to move away from one-size-fits-all-medicine...

View Sample

FREE Email Newsletter

Hydrogen sulfide could help lower blood pressure

January 29, 2015 4:30 pm | by Univ. of Exter Medical School | News | Comments

A gas that gives rotten eggs their distinctive odor could one day form the basis of new cardiovascular therapies. Research has indicated that a new compound, called AP39, which generates minute quantities of the gas hydrogen sulfide inside cells, could be beneficial in cases of high blood pressure and diseases of the blood vessels that occur with aging and diabetes.

New clues about a brain protein with high affinity for valium

January 29, 2015 4:18 pm | by Karen McNulty Walsh, Brookhaven National Laboratory | News | Comments

Valium, one of the best known antianxiety drugs, produces its calming effects by binding with a particular protein in the brain. But the drug has an almost equally strong affinity for a completely different protein. Understanding this secondary interaction might offer clues about Valium's side effects and point the way to more effective drugs.

Genetically engineered antibodies show enhanced HIV-fighting abilities

January 29, 2015 4:06 pm | by Kimm Fesenmaier, Caltech | News | Comments

Capitalizing on a new insight into HIV's strategy for evading antibodies, Caltech researchers have developed antibody-based molecules that are more than 100 times better than our bodies' own defenses at binding to and neutralizing HIV, when tested in vitro. The work suggests a novel approach that could be used to engineer more effective HIV-fighting drugs.

Advertisement

Neutron beams reveal how two potential pieces of Parkinson’s puzzle fit

January 29, 2015 11:44 am | by Chad Boutin, NIST | News | Comments

To understand diseases like Parkinson’s, the tiniest of puzzles may hold big answers. That’s why a team including scientists from NIST have determined how two potentially key pieces of the Parkinson’s puzzle fit together, in an effort to reveal how the still poorly understood illness develops and affects its victims.

X-ray study reveals division of labor in cell health protein

January 29, 2015 11:24 am | by SLAC Office of Communications | News | Comments

Researchers working in part at the SLAC National Accelerator Laboratory have discovered that a key protein for cell health, which has recently been linked to diabetes, cancer and other diseases, can multitask by having two identical protein parts divide labor. The TH enzyme, short for transhydrogenase, is a crucial protein for most forms of life. In humans and other higher organisms, it works within mitochondria.

Why upper motor neurons degenerate in ALS

January 29, 2015 8:44 am | by Marla Paul, Northwestern Univ. | News | Comments

For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology. ALS, or amyotrophic lateral sclerosis, is a fatal neuromuscular disorder marked by the degeneration of motor neurons, which causes muscle weakness and impaired speaking, swallowing and breathing that leads to paralysis and death.

Researchers design tailored tissue adhesives

January 29, 2015 8:17 am | by Anne Trafton, MIT News Office | News | Comments

After undergoing surgery to remove diseased sections of the colon, up to 30% of patients experience leakage from their sutures, which can cause life-threatening complications. Many efforts are under way to create new tissue glues that can help seal surgical incisions and prevent such complications; now, a new study reveals that the effectiveness of such glues hinges on the state of the tissue in which they are being used.

Ancient Israeli skull may document migration from Africa

January 28, 2015 1:17 pm | by Malcolm Ritter, AP Science Writer, Associated Press | News | Comments

Long ago, humans left their evolutionary cradle in Africa and passed through the Middle East on their way to Europe. Now scientists have found the first fossil remains that appear to document that journey, a partial skull from an Israeli cave. The skull dates from around 55,000 years ago, fitting into the period when scientists had thought the migrants inhabited the area.

Advertisement

New mechanism unlocked for evolution of green fluorescent protein

January 28, 2015 10:51 am | by Jenny Green, Arizona State Univ. | News | Comments

A primary challenge in the biosciences is to understand the way major evolutionary changes in nature are accomplished. Sometimes the route turns out to be very simple. A group of scientists showed, for the first time, that a hinge migration mechanism, driven solely by long-range dynamic motions, can be the key for evolution of a green-to-red photoconvertible phenotype in a green fluorescent protein.

Beer compound could help fend off Alzheimer’s

January 28, 2015 10:40 am | by American Chemical Society | News | Comments

The health-promoting perks of wine have attracted the spotlight recently, leaving beer in the shadows. But scientists are discovering new ways in which the latter could be a more healthful beverage than once thought. They’re now reporting that a compound from hops could protect brain cells from damage, and potentially slow the development of disorders such as Alzheimer’s and Parkinson’s diseases.

Ribose-seq identifies, locates ribonucleotides in genomic DNA

January 28, 2015 10:10 am | by John Toon, Georgia Institute of Technology | News | Comments

Ribonucleotides, units of RNA, can become embedded in genomic DNA during processes such as DNA replication and repair, affecting the stability of the genome by contributing to DNA fragility and mutability. Scientists have known about the presence of ribonucleotides in DNA, but until now had not been able to determine exactly what they are and where they are located in the DNA sequences.

Drug combo suppresses growth of late-stage prostate cancer tumors

January 28, 2015 8:31 am | by Natalie van Hoose, Purdue Univ. | News | Comments

Low doses of metformin, a widely used diabetes medication and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue Univ. study finds. Prostate cancer causes the second-highest number of cancer-related deaths in men in the U.S., and methods of treating advanced prostate cancer are limited.

Man trumps dog: Earlier assumption about BPA exposure confirmed

January 28, 2015 8:18 am | by Mary Beckman, Pacific Northwest National Laboratory | News | Comments

Coating the mouth with BPA-containing food does not lead to higher than expected levels of BPA in blood, according to a new study. The study concludes that oral exposure does not create a risk for high exposures. BPA, also known as bisphenol A, is used to make some plastics and to seal canned food containers against bacterial contamination. Food, which picks up trace amounts of BPA from packaging, is the major source of human exposure.

Advertisement

Synthetic amino acid enables safe, new biotechnology solutions

January 26, 2015 12:13 pm | by Bill Hathaway, Yale Univ. | News | Comments

Scientists from Yale Univ. have devised a way to ensure genetically modified organisms (GMOs) can be safely confined in the environment, overcoming a major obstacle to widespread use of GMOs in agriculture, energy production, waste management and medicine.

Nanoshuttle wear and tear: It’s the mileage, not the age

January 26, 2015 11:36 am | by Holly Evarts, Columbia Univ. | News | Comments

As nanomachine design rapidly advances, researchers are moving from wondering if the nanomachine works to how long it will work. This is an especially important question as there are so many potential applications, for instance, for medical uses, including drug delivery, early diagnosis, disease monitoring, instrumentation and surgery.

Potential new drug target for lung cancer

January 26, 2015 11:23 am | by Allison Perry, Univ. of Kentucky | Videos | Comments

A new study by Univ. of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer. Cancer cells undergo metabolic alterations to meet the increased energy demands that support their excess growth and survival.

Chemists find a way to unboil eggs

January 26, 2015 9:25 am | by Janet Wilson, Univ. of California, Irvine | News | Comments

Univ. of California, Irvine and Australian chemists have figured out how to unboil egg whites, an innovation that could dramatically reduce costs for cancer treatments, food production and other segments of the $160 billion global biotechnology industry, according to findings published in ChemBioChem.

How cancer turns good cells to the dark side

January 26, 2015 8:38 am | by Mike Williams, Rice Univ. | News | Comments

Cancer uses a little-understood element of cell signaling to hijack the communication process and spread, according to Rice Univ. researchers. A new computational study by researchers at the Rice-based Center for Theoretical Biological Physics shows how cancer cells take advantage of the system by which cells communicate with their neighbors as they pass messages to “be like me” or “be not like me.”

Trust your gut

January 23, 2015 9:01 am | by Laura Bailey, Univ. of Michigan | News | Comments

E. coli usually brings to mind food poisoning and beach closures, but researchers recently discovered a protein in E. coli that inhibits the accumulation of potentially toxic amyloids, a hallmark of diseases such as Parkinson's. Amyloids are formed by proteins that misfold and group together, and when amyloids assemble at the wrong place or time, they can damage brain tissue and cause cell death.

Rare neurological disease shines light on health of essential nerve cells

January 23, 2015 8:35 am | by David Tennebaum, Univ. of Wisconsin-Madison | News | Comments

Ian Duncan is a Scotsman with the iron discipline and stamina of a competitive marathoner, triathlete and cross-country skier. As a neuroscientist at the School of Veterinary Medicine at the Univ. of Wisconsin-Madison, he’s applied his tenacity to a rare genetic disorder. Known as Pelizaeus Merzbacher disease or PMD, it’s a devastating neurological condition that, in its most severe form, kills infants weeks after birth.

Pictured together for the first time: A chemokine and its receptor

January 23, 2015 8:12 am | by Heather Buschman, Univ. of California, San Diego | News | Comments

Researchers report the first crystal structure of the cellular receptor CXCR4 bound to an immune signaling protein called a chemokine. The structure, published in Science, answers longstanding questions about a molecular interaction that plays an important role in human development, immune responses, cancer metastasis and HIV infections.

Advances in PCR Improve Health of Animal Research Colonies

January 22, 2015 3:59 pm | by Ken Henderson, Director of R&D, Charles River Laboratories, Wilmington, Mass. | Articles | Comments

Reducing the use of laboratory animals has been a long-term goal in biological research. Many in vivo assays, like rabbit endotoxin testing or mouse antibody production testing to detect viral contaminants have largely been replaced by in vitro enzyme or PCR-based assays.

One dose, then surgery: A new way to test brain tumor drugs

January 22, 2015 1:18 pm | by Marilynn Marchione, AP Chief Medical Writer, Associated Press | News | Comments

Lori Simons took the bright orange pill at 3 a.m. Eight hours later, doctors sliced into her brain, looking for signs that the drug was working. She is taking part in one of the most unusual cancer experiments in the nation. With special permission from the Food and Drug Administration and multiple drug companies, an Arizona hospital is testing medicines very early in development and never tried on brain tumors before.

Biological safety lock for genetically modified organisms

January 22, 2015 1:17 pm | by Stephanie Dutchen, Harvard Medical School | News | Comments

The creation of genetically modified and entirely synthetic organisms continues to generate excitement as well as worry. Such organisms are already churning out insulin and other drug ingredients, helping produce biofuels and teaching scientists about human disease. While the risks can be exaggerated to frightening effect, modified organisms do have the potential to upset natural ecosystems if they were to escape.

Researchers reveal how the mundane can be meaningful, remembered

January 22, 2015 11:36 am | by James Devitt, New York Univ. | News | Comments

It’s not surprising that our memories of highly emotional events, such as 9/11 or the birth of a child, are quite strong. But can these events change our memories of the past? In a study published in Nature, New York Univ. researchers report that emotional learning can lead to the strengthening of older memories.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading